Tylenol Cold Gelcaps Recall Issued for 2.45M Packages by J&J
About 2.45 million packages of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps have been recalled by Johnson & Johnson after it was discovered that they may have too much of one ingredient.
The Tylenol Cold Gelcaps recall was announced on Monday by Johnson & Johnson’s McNeil Consumer Healthcare Division after a product sample showed higher amounts of Chlorpheniramine Ammonio Acetate (CPAA) than expected.
There have been no reports of illnesses related to the Tylenol recall and the company claims that there is little risk of adverse health events. However, this is yet another recall issued by Johnson & Johnson due to manufacturing problems associated with their over-the-counter medications, which cost the company an estimated $900 million in sales last year.
Tylenol Autism Lawsuit
The recall is being conducted on the retail and wholesale level, which means that Johnson & Johnson is not asking consumers to return the bad batches of Tylenol and says that they should use them as normal.
The recall affects the following products:
- Tylenol Cold Multi-Symptom Nighttime Rapid Release Gels 24 RR Gelcaps with UPC Code 300450395245 and Lot Numbers AMA277, APA059, APA162, ASA025, APA237, ASA072, ASA208, and BAA008.
- Tylenol Cold Multi-Symptom Rapid Release Gels Day/Night 12+8 RR Gelcaps with UPC Code 300450396204 and Lot Numbers AMF034, BAF005, BAF027, and BCF080.
- Tylenol Cold Multi-Symptom Rapid Release Gels Day/Night 36+24 RR Gelcaps with UPC Code 300450396600 and Lot Numbers BBF001, BCF060, and BCF079.
The lot numbers are located on the side of the carton label.
This is the largest Johnson & Johnson recall since January, when the company announced a massive over-the-counter drug recall of 43 million bottles of a variety of products, including Tylenol, Benadryl and Sudafed because of improperly cleaned equipment used during the manufacturing process.
Consumers with questions can contact the company’s Consumer Care Center at 1-888-222-6036.
"*" indicates required fields
More Top Stories
Although Suboxone settlements have been paid to resolve antitrust violations, users who suffered damages due to tooth decay from Suboxone film must pursue individual product liability lawsuits
With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to warn doctors to conduct hearing tests, which could have helped a woman avoid permanent hearing damage.